GlassScriptPhysician profile
Harry M Rutland
NPI 1528163748
$6,080.67
in general payments reported to CMS, 2019-2025
52 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,088 · 2020: $260 · 2021: $950 · 2022: $826 · 2023: $886 · 2024: $1,056 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,921 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,920.89 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $555.76 | 2019-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $445.80 | 2023-2025 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $412.04 | 2019-2023 | |
| Astellas Pharma US INC | $405.23 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Boston Scientific Corporation | $365.27 | 2019-2025 | Lumenis Pulse 100h, Solyx Sis System, Greenlight Xps |
| Procept Biorobotics Corporation | $318.75 | 2019-2024 | Aquabeam Robotic System, Aquabeam System |
| Medtronic, INC. | $240.35 | 2021-2025 | Interstim |
| Dendreon Pharmaceuticals LLC | $235.24 | 2019-2025 | Provenge |
| Tolmar, INC. | $219.58 | 2023-2025 | Jatenzo, Eligard |
| Pfizer INC. | $189.35 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $187.53 | 2019-2025 | |
| Teleflex LLC | $170.87 | 2021-2025 | Urolift, Barrigel |
| Srs Medical Systems, INC. | $154.16 | 2021 | |
| Tempus Ai, INC | $144.34 | 2024-2025 | Xt Cdx |
| Karl Storz Endoscopy-America | $142.85 | 2019 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $136.27 | 2024-2025 | Aveed, Xiaflex |
| Astrazeneca Pharmaceuticals LP | $123.16 | 2019-2025 | Imfinzi, Lynparza |
| Myovant Sciences INC. | $119.78 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $108.90 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $99.51 | 2022-2024 | |
| Photocure INC | $97.52 | 2019 | |
| Merck Sharp & Dohme LLC | $96.92 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Janssen Biotech, INC. | $89.19 | 2019-2025 | Erleada |
| Olympus America INC. | $88.42 | 2022-2025 | Itind System, Soltive |
| Coloplast Corp | $86.82 | 2022-2024 | Speedicath |
| Tolmar Pharmaceuticals, INC. | $77.18 | 2021-2022 | |
| Antares Pharma, INC. | $74.84 | 2019 | |
| Laborie Medical Technologies Corp. | $73.16 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Novartis Pharmaceuticals Corporation | $52.79 | 2025 | |
| Abbott Laboratories | $52.40 | 2019-2020 | |
| Calyxo, INC. | $44.39 | 2025 | Cvac Aspiration System |
| Rochester Medical Corporation | $42.13 | 2020-2021 | |
| Neotract INC. | $38.95 | 2020 | |
| Urogen Pharma, INC. | $36.56 | 2025 | |
| Angiodynamics, INC. | $34.73 | 2022 | |
| Acerus Pharmaceuticals Corporation | $28.84 | 2021 | |
| Abc Home Medical Supply, INC. | $24.78 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $24.77 | 2022 | |
| Dentsply Ih Ab | $22.77 | 2024 | Lofric |
| Ethicon US, LLC | $20.95 | 2025 | Vistaseal |
| Urovant Sciences INC | $20.60 | 2022 | |
| Valencia Technologies Corporation | $20.39 | 2025 | Ecoin Device Kit |
| Immunitybio, INC. | $17.41 | 2025 | |
| Innovation Technologies INC | $17.28 | 2024 | Irrisept |
| Myriad Genetic Laboratories, INC. | $17.27 | 2021 | |
| Travere Therapeutics, INC. | $16.44 | 2020-2022 | |
| Amgen INC. | $15.75 | 2019 | |
| Baxter Healthcare | $15.69 | 2019 | |
| Verity Pharmaceuticals INC. | $15.54 | 2024 | Trelstar |
| Philips North America LLC | $14.28 | 2021 | |
| Bioprotect Medical, INC. | $13.63 | 2025 | Bioprotect Balloon Implant System |
| Axonics, INC. | $13.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harry Rutland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.